Truvestments Capital’s Celgene Corp CELG Stock Holding History

Truvestments Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,859	Closed	-$582K	–	703
2019 Q3	$582K	Sell	5,859 -2,040	-26%	-$194K	0.38%	73
2019 Q2	$730K	Buy	7,899 +756	+11%	+$71.8K	0.49%	58
2019 Q1	$674K	Buy	+7,143	New	+$625K	0.52%	53
2018 Q3	$638K	Buy	7,134 +1,107	+18%	+$97.8K	0.31%	88
2018 Q2	$479K	Buy	+6,027	New	+$500K	0.3%	98

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Truvestments Capital's CELG Position: Q4 2019 in Review

Truvestments Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 5,859 shares — an estimated $582K sold.

Truvestments Capital first reported a position in CELG in Q2 2018 and held it in 5 quarters. The position peaked at $730K in Q2 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Truvestments Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Truvestments Capital sold 5,859 Celgene Corp shares in Q4 2019, an estimated $582K.
Truvestments Capital first reported a position in Celgene Corp in Q2 2018 and held it in 5 quarters.
Truvestments Capital's Celgene Corp position peaked at $730K in Q2 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Truvestments Capital's 13F filing for Q4 2019, filed 29 Jan 2020.